Chemotaxis of human peripheral blood eosinophils to 2-arachidonoylglycerol: Comparison with other eosinophil chemoattractants

International Archives of Allergy and Immunology

Volumn 140, Issue SUPPL. 1, 2006, Pages 3-7

  Kishimoto, Seishi ^a   Oka, Saori ^a   Gokoh, Maiko ^a   Sugiura, Takayuki ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

2 Arachidonoylglycerol; Cannabinoid receptor; Chemotaxis; Eosinophil

Indexed keywords

2 ARACHIDONOYLGLYCEROL; CHEMOATTRACTANT; EOSINOPHIL CHEMOTACTIC FACTOR; EOTAXIN; RANTES; THROMBOCYTE ACTIVATING FACTOR;

ALLERGY; BLOOD DONOR; CELL METABOLISM; CELL MIGRATION; CELL SEPARATION; CELL STIMULATION; CHEMOKINESIS; COCULTURE; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; EOSINOPHIL; HUMAN; HUMAN CELL; INCUBATION TIME; INFLAMMATION; LEUKOCYTE MIGRATION; NEUTROPHIL CHEMOTAXIS; NORMAL HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ARACHIDONIC ACIDS; CELLS, CULTURED; CHEMOKINES, CC; CHEMOTACTIC FACTORS, EOSINOPHIL; CHEMOTAXIS, LEUKOCYTE; EOSINOPHILS; GLYCERIDES; HUMANS; PLATELET ACTIVATING FACTOR; RANTES; RECEPTOR, CANNABINOID, CB2;

EID: 33745065869     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092704     Document Type: Conference Paper

References (31)

1. Pertwee RG: Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther 1997;74:129-180.
2. Schlicker E, Kathmann M: Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol Sci 2001;22:565-572.
3. Munro S, Thomas KL, Abu-Shaar M: Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993;365:61-65.
4. Galiegue S, Mary S, Marchand J, Dussossoy D, Carriere D, Carayon P, Bouaboula M, Shire D, Le Fur G, Casellas P: Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 1995;232:54-61.
5. Klein TW, Newton C, Larsen K, Lu L, Perkins I, Nong L, Friedman H: The cannabinoid system and immune modulation. J Leukoc Biol 2003;74:486-496.
6. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R: Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992;258:1946-1949.
7. Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A, Waku K: 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 1995;215:89-97.
8. Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, Compton DR, Pertwee RG, Griffin G, Bayewitch M, Barg J, Vogel Z: Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 1995;50:83-90.
9. Di Marzo V: Endocannabinoid and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance. Biochim Biophys Acta 1998;1392:153-175.
10. Mechoulam R, Fride E, Di Marzo V: Endocannabinoids. Eur J Pharmacol 1998;359:1-18.
11. Sugiura T, Kodaka T, Nakane S, Miyashita T, Kondo S, Suhara Y, Takayama H, Waku K, Seki C, Baba N, Ishima Y: Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds. J Biol Chem 1999;274:2794-2801.
12. Sugiura T, Kondo S, Kishimoto S, Miyashita T, Nakane S, Kodaka T, Suhara Y, Takayama H, Waku K: Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells. J Biol Chem 2000;275:605-612.
13. Sugiura T, Waku K: 2-Arachidonoylglycerol and the cannabinoid receptors. Chem Phys Lipids 2000;108:89-106.
14. Sugiura T, Kobayashi Y, Oka S, Waku K: Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance. Prostaglandins Leukot Essent Fatty Acids 2002;66:173-192.
15. Kobayashi Y, Arai S, Waku K, Sugiura T: Activation by 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, of p42/44 mitogen-activated protein kinase in HL-60 cells. J Biochem 2001;129:665-669.
16. Sugiura T, Kishimoto S, Oka S, Gokoh M, Waku K: Metabolism and physiological significance of anandamide and 2-arachidonoylglycerol, endogenous cannabinoid receptor ligands; in Fonteh AN, Wykle RL (eds): Arachidonate Remodeling and Inflammation. Basel, Birkhäuser Verlag, 2004, pp 211-237.
17. Kishimoto S, Kobayashi Y, Oka S, Gokoh M, Waku K, Sugiura T: 2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces accelerated production of chemokines in HL-60 cells. J Biochem 2004;135:517-524.
18. Gokoh M, Kishimoto S, Oka S, Mori M, Waku K, Ishima Y, Sugiura T: 2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces rapid actin polymerization in HL-60 cells differentiated into macrophage-like cells. Biochem J 2005;386:583-589.
19. Kishimoto S, Gokoh M, Oka S, Muramatsu M, Kajiwara T, Waku K, Sugiura T: 2-Arachidonoylglycerol induces the migration of HL-60 cells differentiated into macrophage-like cells and human peripheral blood monocytes through the cannabinoid CB2 receptor-dependent mechanism. J Biol Chem 2003;278:24469-24475.
20. Oka S, Ikeda S, Kishimoto S, Gokoh M, Yamagimoto S, Waku K, Sugiura T: 2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces the migration of EoL-1 human eosinophilic leukemia cells and human peripheral blood eosinophils. J Leukoc Biol 2004;76:1002-1009.
21. 2+ in neuroblastoma x glioma hybrid NG108-15 cells. Biochem Biophys Res Commun 1996;229:58-64.
22. Kishimoto S, Shimadzu W, Izumi T, Shimizu T, Fukuda T, Makino S, Sugiura T, Waku K: Regulation by IL-5 of the expression of functional platelet-activating factor receptors on human eosinophils. J Immunol 1996;157:4126-4132.
23. Xia L, Sperandio M, Yago T, McDaniel JM, Cummings RD, Pearson-White S, Ley K, McEver RP: P-selectin glycoprotein ligand-1-deficient mice have impaired leukocyte tethering to E-selectin under flow. J Clin Invest 2002;109:939-950.
24. Wardlaw AJ, Moqbel R, Kay AB: Eosinophils: biology and role in disease. Adv Immunol 1995;60:151-266.
25. Broide D, Sriramatao P: Eosinophil trafficking to sites of allergic inflammation. Immunnol Rev 2001;179:163-172.
26. Schwenk U, Schroder JM: 5-Oxo-eicosanoids are potent eosinophil chemotactic factors. Functional characterization and structural requirements. J Biol Chem 1995;270:15029-15036.
27. Powell WS, Chung D, Gravel S: 5-Oxo-6,8,11,14-eicosatetraenoic acid is a potent stimulator of human eosinophil migration. J Immunol 1995;154:4123-4132.
28. Varga K, Wagner JA, Bridgen DT, Kunos G: Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension. FASEB J 1998;12:1035-1044.
29. Di Marzo V, Bisogno T, De Petrocellis L, Melck D, Orlando P, Wagner JA, Kunos G: Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages. Eur J Biochem 1999;264:258-267.
30. Berdyshev EV, Schmid PC, Krebsbach RJ, Schimid HHO: Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells. FASEB J 2001;15:2171-2178.
31. Oka S, Yanagimoto S, Ikeda S, Gokoh M, Kishimoto S, Waku K, Ishima Y, Sugiura T: Evidence for the involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in 12-O-tetradecanoylphorbol-13- acetate-induced acute inflammation in mouse ear. J Biol Chem 2005;280:18488-18497.